Evidence map›Paper›PMID 34471230›Full record

ArticleLeukemia2021

Correction: Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse: best practice recommendations of the EBMT Chronic Malignancies Working Party.

Donal P McLornan, Juan Carlos Hernandez-Boluda, Tomasz Czerw, Nicholas Cross, H Joachim Deeg, Marcus Ditschkowski, Mufaddal T Moonim, Nicola Polverelli, Marie Robin, Mahmoud Aljurf and 3 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Leukemia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Donal P McLornanDepartment of Haematology, Guy's and St. Thomas' NHS Foundation Trust and University College Hospitals, London, UK. donal.mclornan@nhs.net.ORCID http://orcid.org/0000-0003-1224-091X
Juan Carlos Hernandez-BoludaHospital Clinico Universitario, Valencia, Spain.ORCID http://orcid.org/0000-0002-4289-3113
Tomasz CzerwMaria Sklodowska-Curie Institute, Gliwice, Poland.ORCID http://orcid.org/0000-0003-3108-4035
Nicholas CrossNational Genetics Reference Laboratory (Wessex), Salisbury District Hospital, Salisbury, UK.ORCID http://orcid.org/0000-0001-5481-2555
H Joachim DeegFred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-4426-9023
Marcus DitschkowskiDepartment for Bone Marrow Transplantation, University of Essen, Essen, Germany.
Mufaddal T MoonimDepartment of Histopathology, Imperial College Healthcare NHS Trust, London, UK.
Nicola PolverelliUnit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences-University of Brescia, ASST Spedali Civili, Brescia, Italy.ORCID http://orcid.org/0000-0001-6297-9697
Marie RobinHopital Saint-Louis, APHP, Université de Paris, Paris, France.ORCID http://orcid.org/0000-0003-1388-9876
Mahmoud AljurfOncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Eibhlin ConneallyHaematology Department, St. James Hospital, Dublin, Ireland.
Patrick HaydenHaematology Department, St. James Hospital, Dublin, Ireland.
Ibrahim Yakoub-AghaCHU de Lille, Univ Lille, INSERM U1286, Infinite, Lille, France. ibrahim.yakoubagha@chru-lille.fr.ORCID http://orcid.org/0000-0003-4524-8782

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34471230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.